Penumbra Newsroom

RBC Capital Maintains Penumbra(PEN.US) With Buy Rating, Raises Target Price to $285

Futu NewsDec 19 18:34

Penumbra Is Maintained at Buy by Truist Securities

Dow JonesDec 18 23:37

Penumbra Analyst Ratings

BenzingaDec 18 23:27

Truist Financial Maintains Penumbra(PEN.US) With Buy Rating, Raises Target Price to $285

Futu NewsDec 18 21:33

Oppenheimer Maintains Penumbra(PEN.US) With Buy Rating, Maintains Target Price $275

Futu NewsDec 17 21:31

Penumbra Initiated at Outperform by Oppenheimer

Dow JonesDec 17 19:52

Oppenheimer Initiates Penumbra(PEN.US) With Buy Rating, Announces Target Price $275

Futu NewsDec 17 05:31

Citi Maintains Penumbra(PEN.US) With Hold Rating, Raises Target Price to $245

Futu NewsDec 11 20:33

Wells Fargo Maintains Penumbra(PEN.US) With Buy Rating, Cuts Target Price to $275

Futu NewsDec 11 19:33

Positive Outlook for Penumbra: Buy Rating Driven by THUNDER Trial Success and Market Growth Prospects

TipRanksDec 11 19:08

Penumbra Is Maintained at Buy by Canaccord Genuity

Dow JonesDec 10 01:38

Penumbra Analyst Ratings

BenzingaDec 10 01:29

CCORF Maintains Penumbra(PEN.US) With Buy Rating, Raises Target Price to $323

Futu NewsDec 9 21:31

Leerink Partners Sticks to Their Buy Rating for Penumbra (PEN)

TipRanksNov 28 17:29

Penumbra Is Maintained at Buy by BTIG

Dow JonesNov 27 01:23

Penumbra Analyst Ratings

BenzingaNov 27 01:14

BTIG Maintains Penumbra(PEN.US) With Buy Rating, Raises Target Price to $270

Futu NewsNov 26 21:31

Cautious Hold Recommendation Amid Uncertainty Following FDA Clearance of Penumbra's Element Vascular Access System

TipRanksNov 26 17:58

Penumbra's Prospective Growth Amidst Market Dynamics Justifies Hold Rating

TipRanksNov 22 19:27

Penumbra Is Maintained at Overweight by Piper Sandler

Dow JonesNov 21 02:13